Aging Clinical Trial
— OptiStimOfficial title:
Optimizing Transcranial Direct Current Stimulation (tDCS) to Improve Dual Task Gait and Balance in Older Adults
NCT number | NCT04295798 |
Other study ID # | 2019-23 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | February 10, 2020 |
Est. completion date | March 2, 2023 |
Verified date | March 2023 |
Source | Hebrew SeniorLife |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this study is to determine the acute effects of single sessions of personalized tDCS, traditional tDCS, and sham stimulation on dual task standing and walking in older adults who are free of overt disease yet who present with poor baseline dual task performance.
Status | Completed |
Enrollment | 33 |
Est. completion date | March 2, 2023 |
Est. primary completion date | March 2, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 65 Years to 85 Years |
Eligibility | Inclusion Criteria: - Men and women aged 65-85 years - Poor dual task performance, defined as a preferred gait speed that is >20% slower when walking and simultaneously performing verbalized serial subtractions (i.e., dual tasking), as compared to walking normally (i.e. single tasking) Exclusion Criteria: - Unwillingness to cooperate or participate in the study protocol - An inability to walk or stand for 30 continuous seconds without an assistive device - A diagnosis of a gait disorder, Parkinson's disease, Alzheimer's disease or dementia, multiple sclerosis, previous stroke or other neurodegenerative disorder - Self-report of acute illness, injury or other unstable medical condition; Any report of severe lower-extremity arthritis or pain, physician-diagnosis of peripheral neuropathy, or other peripheral neuromuscular disease that may confound the effects of tDCS on gait or postural control - Use of antipsychotics, anti-seizure, benzodiazepines, or other neuroactive medications - Severe depression defined by a Geriatric Depression Scale score greater than 11; - Any report or physician-diagnosis of schizophrenia, bipolar disorder or other psychiatric illness - Contraindications to MRI or tDCS, including reported seizure within the past two years, use of neuro-active drugs, the risk of metal objects anywhere in the body, self-reported presence of specific implanted medical devices (e.g., deep brain stimulator, medication infusion pump, cochlear implant, pacemaker, etc.), or the presence of any active dermatological condition, such as eczema, on the scalp |
Country | Name | City | State |
---|---|---|---|
United States | Hebrew Rehabilitation Center | Roslindale | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Hebrew SeniorLife |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dual task cost to gait speed | Assesses the percent difference in gait speed between single and dual task walking conditions. | Change from baseline to immediate post-tDCS follow-up | |
Primary | Dual task cost to postural sway speed | Assesses the percent difference in postural sway speed between single and dual task standing conditions. | Change from baseline to immediate post-tDCS follow-up | |
Secondary | Dual task cost to stride time variability | Assesses the percent difference in stride time variability between single and dual task walking conditions. | Change from baseline to immediate post-tDCS follow-up | |
Secondary | Single task gait speed | Assesses gait speed within single task walking conditions | Change from baseline to immediate post-tDCS follow-up | |
Secondary | Dual task gait speed | Assesses gait speed within dual task walking conditions | Change from baseline to immediate post-tDCS follow-up | |
Secondary | Single task stride time variability | Assesses stride time variability within single task walking conditions | Change from baseline to immediate post-tDCS follow-up | |
Secondary | Dual task stride time variability | Assesses stride time variability within dual task walking conditions | Change from baseline to immediate post-tDCS follow-up | |
Secondary | Dual task cost to postural sway area | Assesses the percent difference in postural sway elliptical area between single and dual task standing conditions | Change from baseline to immediate post-tDCS follow-up | |
Secondary | Single task postural sway speed | Assesses postural sway speed within single task standing conditions | Change from baseline to immediate post-tDCS follow-up | |
Secondary | Dual task postural sway speed | Assesses postural sway speed within dual task standing conditions | Change from baseline to immediate post-tDCS follow-up | |
Secondary | Single task postural sway area | Assesses postural sway area within single task standing conditions | Change from baseline to immediate post-tDCS follow-up | |
Secondary | Dual task postural sway area | Assesses postural sway area within dual task standing conditions | Change from baseline to immediate post-tDCS follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
Completed |
NCT05293730 -
Trial of the Impact of the Electronic Frailty Integrated With Social Needs
|
N/A | |
Recruiting |
NCT03932162 -
Gene Expression Changes In Young and Geriatric Skin
|
Early Phase 1 | |
Completed |
NCT04064528 -
Effects of Age on Amino Acid Delivery to Tendon
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05543980 -
Leg Heat Therapy in Elderly Individuals
|
Phase 2 | |
Recruiting |
NCT05566938 -
Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly
|
N/A | |
Completed |
NCT04894929 -
Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement
|
N/A | |
Not yet recruiting |
NCT06071130 -
Emotion, Aging, and Decision Making
|
N/A | |
Enrolling by invitation |
NCT04641663 -
Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST)
|
N/A | |
Completed |
NCT04088006 -
The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity
|
N/A | |
Completed |
NCT03695081 -
Patient Pathway Pharmacist - Optimal Drug-related Care
|
N/A | |
Recruiting |
NCT05424263 -
Acetate and Age-associated Arterial Dysfunction
|
Phase 2 | |
Completed |
NCT05601713 -
Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
|
N/A | |
Completed |
NCT04551339 -
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19
|
N/A | |
Recruiting |
NCT04997577 -
Speech Perception and High Cognitive Demand
|
N/A | |
Completed |
NCT05922475 -
Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training
|
N/A | |
Completed |
NCT04015479 -
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults
|
N/A |